The Anti-tumor Effect of Quinazolinone Derivative Holu-12 on Oral Squamous Cell Carcinoma Cells
碩士 === 慈濟大學 === 藥理暨毒理學碩士班/博士班 === 106 === Oral squamous cell carcinoma (OSCC) is one of the common malignant diseases in the world. Through advances in multimodality therapies for the treatment of OSCC; however, the overall 5-year survival rate for OSCC patients remains at 50% without significant im...
Main Authors: | CHIA, YI-TING, 賈貽婷 |
---|---|
Other Authors: | LAI, KUO-CHU |
Format: | Others |
Language: | zh-TW |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/99ecg4 |
Similar Items
-
Investigations for targeting signaling pathways in the apoptosis induction and anti-metastasis of the novel quinazolinone derivatives in leukemia and oral cancer cells in vitro and anti-tumor activity in vivo
by: Chi-Cheng Lu, et al.
Published: (2012) -
Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo
by: Si-yuan Liang, et al.
Published: (2021-06-01) -
Quinazolinone and Quinazoline Derivatives
Published: (2020) -
Cisplatin-Resistance in Oral Squamous Cell Carcinoma: Regulation by Tumor Cell-Derived Extracellular Vesicles
by: Xin-Hui Khoo, et al.
Published: (2019-08-01) -
Expression of MAGE-A12 in Oral Squamous Cell Carcinoma
by: Nur Mollaoglu, et al.
Published: (2008-01-01)